News 20. März 2024 Spineart raises CHF 20 million to push the boundaries of spinal surgery Spineart, the Geneva-based pioneer in spinal surgery innovations, has successfully secured over CHF 20 million in convertible financing.
Actualités 14. Febr. 2024 L’Université de Fribourg découvre un traitement pour combattre la neuroinflammation liée à l’âge Des scientifiques de l’Université de Fribourg ont découvert un mécanisme révolutionnaire qui pourrait atténuer de manière significative la neuroi...
News 14. Aug. 2023 Bern’s thriving ecosystem for life sciences innovation In the heart of Western Switzerland, the canton of Bern has emerged as a location of choice for companies in the life sciences sector.
News 06. März 2024 Aktiia secures CHF 27 million to combat global hypertension crisis Aktiia, a pioneering Neuchâtel-based start-up specializing in cuffless blood pressure monitoring, has announced a significant financial milestone...
Actualités 30. Jan. 2024 Les Grands Titres de Suisse occidentale (Janvier 2024) Des avancées révolutionnaires dans l’agroalimentaire et la robotique aux réformes économiques stratégiques en passant par la recherche pionnière ...
News 13. Nov. 2023 Bern’s journey to becoming a world-class medtech hub by 2030 The canton of Bern is on a mission to become a leading global medical hub by 2030. By combining an exceptional medical expertise medical expertis...
News 04. Dez. 2023 Bern University of Applied Sciences launches the Institute for Patient-Centered Digital Health The Bern University of Applied Sciences is set to enhance its foothold in medical informatics with the establishment of a new institute dedicated...
News 15. Dez. 2021 La Source launches the H4 collaborative innovation hub With H4, La Source is opening the first collaborative innovation platform dedicated to healthcare in the canton of Vaud.
News 01. Nov. 2023 Bacthera’s Visp plant aims to revolutionize microbiome-based treatments In Visp, Bacthera’s MC4a Center of Excellence readies to manufacture transformative microbiome therapies, notably the Seres Therapteutics’ life-s...
News 14. Nov. 2023 Opening of the Dynamic Imaging Center at sitem-insel in Bern sitem-insel has inaugurated the Dynamic Imaging Center, a groundbreaking facility that introduces a novel approach to X-ray imaging.
News 31. Okt. 2023 Debiopharm invests CHF 30 million in Valais amidst workforce surge Debiopharm Research & Manufacturing has announced an investment of over CHF 30 million in a Martigny lab expansion as staff numbers rise from 150...
News 27. Okt. 2023 Roche uses artificial intelligence for cancer diagnosis Roche is teaming up with Ibex Medical Analytics and Amazon Web Services in the field of artificial intelligence (AI). The goal is to help patholo...
News 03. Nov. 2023 A new gel offers targeted relief for ulcerative colitis patients Researchers at the University of Bern have developed a lipid gel for direct, localized treatment of ulcerative colitis, aiming to reduce side eff...
News 30. Okt. 2023 Compremium’s breakthrough medical device embarks on a NASA voyage Bern-based medtech innovator Compremium has delivered its pioneering Compartmental Compressibility Monitoring System to NASA, a significant leap ...
Headquarters 15. Juni 2023 Open Your HQ Are you a biopharmaceutical company seeking to access the European market? Switzerland could be the perfect location for your commercial headquar...
News 06. Febr. 2024 QUMEA secures investment of 9 million Swiss francs QUMEA has raised funding of 9 million Swiss francs as part of an oversubscribed Series A financing round. With this fresh capital, the digital he...
Actualités 10. Jan. 2024 L’essor remarquable de la chimie-pharma dans le canton du Valais Depuis des décennies, le canton du Valais a cultivé une réputation d’excellente dans les domaines de la chimie et de la pharmaceutique, fusionnan...
Research and Development 11. Juli 2023 Benefit from R&D Switzerland’s pragmatic collaboration between science and industry can help your company expedite the journey of your products to market. Learn h...